159 related articles for article (PubMed ID: 31590640)
1. PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia.
Dias MAB; De Oliveira L; Jeyabalan A; Payne B; Redman CW; Magee L; Poston L; Chappell L; Seed P; von Dadelszen P; Roberts JM;
BMC Pregnancy Childbirth; 2019 Oct; 19(1):343. PubMed ID: 31590640
[TBL] [Abstract][Full Text] [Related]
2. PREPARE: A Stepped-Wedge Cluster-Randomized Trial to Evaluate Whether Risk Stratification Can Reduce Preterm Deliveries Among Patients With Suspected or Confirmed Preterm Preeclampsia.
De Oliveira L; Roberts JM; Jeyabalan A; Blount K; Redman CW; Poston L; Seed PT; Chappell LC; Dias MAB;
Hypertension; 2023 Oct; 80(10):2017-2028. PubMed ID: 37431663
[TBL] [Abstract][Full Text] [Related]
3. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
4. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
5. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
[TBL] [Abstract][Full Text] [Related]
6. PARROT Ireland: Placental growth factor in Assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol.
Hayes-Ryan D; Hemming K; Breathnach F; Cotter A; Devane D; Hunter A; McAuliffe FM; Morrison JJ; Murphy DJ; Khashan A; McElroy B; Murphy A; Dempsey E; O'Donoghue K; Kenny LC
BMJ Open; 2019 Mar; 9(2):e023562. PubMed ID: 30826791
[TBL] [Abstract][Full Text] [Related]
7. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
[TBL] [Abstract][Full Text] [Related]
8. Epidural therapy for the treatment of severe pre-eclampsia in non labouring women.
Ray A; Ray S
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009540. PubMed ID: 29181841
[TBL] [Abstract][Full Text] [Related]
9. Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: The Freiburg preeclampsia H.E.L.P.-Apheresis study.
Winkler K; Contini C; König B; Krumrey B; Pütz G; Zschiedrich S; Pecks U; Stavropoulou D; Prömpeler H; Kunze M; Markfeld-Erol F
Pregnancy Hypertens; 2018 Apr; 12():136-143. PubMed ID: 29858106
[TBL] [Abstract][Full Text] [Related]
10. Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia.
Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dinkel C; Schoedl M; Dilba P; Hund M; Verlohren S
Obstet Gynecol; 2016 Aug; 128(2):261-269. PubMed ID: 27399996
[TBL] [Abstract][Full Text] [Related]
11. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
12. Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2).
Hurrell A; Sparkes J; Duhig K; Seed PT; Myers J; Battersby C; Clark K; Green M; Hunter RM; Shennan AH; Chappell LC; Webster L
Trials; 2022 Sep; 23(1):722. PubMed ID: 36056408
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
14. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.
Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D
Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983
[TBL] [Abstract][Full Text] [Related]
15. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
Sabrià E; Lequerica-Fernández P; Ganuza PL; Ángeles EE; Escudero AI; Martínez-Morillo E; Alvárez FV
Clin Chem Lab Med; 2018 Jan; 56(2):303-311. PubMed ID: 28841572
[TBL] [Abstract][Full Text] [Related]
16. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews.
Shepherd E; Salam RA; Middleton P; Makrides M; McIntyre S; Badawi N; Crowther CA
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012077. PubMed ID: 28786098
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis biomarkers for the prediction of severe adverse outcomes in late-preterm preeclampsia.
Villalain C; Herraiz I; Cantero B; Quezada S; Lopez A; Simón E; Galindo A
Pregnancy Hypertens; 2020 Jan; 19():74-80. PubMed ID: 31927324
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: The PEACOCK study.
Duhig KE; Seed PT; Placzek A; Sparkes J; Hendy E; Gill C; Brockbank A; Shennan AH; Thangaratinam S; Chappell LC
Pregnancy Hypertens; 2021 Jun; 24():90-95. PubMed ID: 33770588
[TBL] [Abstract][Full Text] [Related]
19. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
Frampton GK; Jones J; Rose M; Payne L
Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
[TBL] [Abstract][Full Text] [Related]
20. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]